Combination therapy in the treatment of allergic rhinitis

Allergy and Asthma Proceedings

Volumn 23, Issue 1, 2002, Pages 1-3

  Weinstein, Steven F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Allerg Asthma Specialists Med Grp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DECONGESTIVE AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

DRUG COMBINATION; HUMAN; PERENNIAL RHINITIS; REVIEW;

ADRENAL CORTEX HORMONES; DRUG THERAPY, COMBINATION; HISTAMINE H1 ANTAGONISTS; HUMANS; LEUKOTRIENE ANTAGONISTS; NASAL DECONGESTANTS; RHINITIS, ALLERGIC, PERENNIAL;

EID: 0036358989     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Meltzer E. The prevalence and medical economic impact of allergic rhinitis in the United States. J Allergy Clin Immunol 99:S805-S828, 1997.
2. Scadding GK. Clinical assessment of antihistamines in rhinitis. Clin Exp Allergy 29:77-81, 1999.
3. Bronsky E, Boggs P, Findlay S, et al. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol 96:139-147, 1995.
4. Horak F, Toth J, Marks B, et al. Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion. Allergy 53:849-856, 1998.
5. Sussman G, Mason J, Compton D, et al. The efficacy and safety of fexofenadine HCI and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. J Allergy Clin Immunol 104:100-106, 1999.
6. Corren J, Harris A, Aaronson D, et al. Efficacy and safety of loratadine plus pseudoephedrine patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 100:781-788, 1997.
7. Storms W, Bodman S, Nathan R, et al. SCH 434: A new antihistamine/decongestant for seasonal allergic rhinitis. J Allergy Clin Immunol 83:1083-1090, 1989.
8. Stempel D, and Thomas M. Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines. Am J Manag Care 4:89-96, 1998.
9. 1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 317:1624-1629, 1998.
10. Purello-D'Ambrosio F, Isola S, Ricciardi L, et al. A controlled study on the effectiveness of loratadine in combination with flunisolide in the treatment of nonallergic rhinitis with eosinophilia (NARES). Clin Exp Allergy 29:1143-1147, 1999
11. Simpson RJ. Budesonide and terfenadine, separately and in combination, in the treatment of hay fever. Ann Allergy 73:497-502, 1994.
12. Ratner P, van Bavel J, Martin B, et al. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract 47:118-125, 1998.
13. Ortolani C, Foresi A, Di Lorenzo G, et al A double-blind, placebocontrolled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. Allergy 54: 1173-1180, 1999.
14. Negrini A, Troise C, Voltolini S, et al. Oral antihistamine/decongestant treatment compared with intranasal corticosteroids in seasonal allergic rhinitis. Clin Exp Allergy 25:60-65, 1995.
15. Creticos P, Peters S, Adkinson F, et al, Peptide leukotriene release after antigen challenge in patients with sensitivity to ragweed. N Engl J Med 310:1626-1630, 1984.
16. 4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans. Clin Allergy 16:289-297, 1986.
17. 4 in allergic rhinitis. Ann Allergy 60:537-540, 1988.
18. Fujita M, Yonetomi Y, Shimouchi K, et al. Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs. Eur J Pharmacol 369:349-356, 1999.
19. Knapp HR. Reduced allergen-induced nasal congestion, and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med 323:1745-1748, 1990.
20. Numata T, Konno A, Yamakosht T, et al. Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy. Ann Otol Rhinol Laryngol 108:467-473, 1999.
21. 4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 151:1734-1739, 1995.
22. Grossman J, Ratner P, Nathan R, et al. Pranlukast (Ultair™, SB 205312, ONO-1078), an oral leukotriene receptor antagonist, relieves symptoms in patients with seasonal allergic rhinitis (SAR). J Allergy Clin Immunol 99:S443, 1997.
23. Malmstrom K, Hampel F, Philip G, et al. Montelukast in the treatment of spring allergic rhinitis in a large, double-blind, randomized, placebo-controlled study. J Allergy Clin Immunol 107:S157, 2001.
24. Pullerits T, Praks L, Skoogh B, et al. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Care Med 159:1814-1818, 1999.
25. Meltzer E, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 105:917-922, 2000.
26. Lis K, Malmstrom K, Nayak A, et al. Treatment of fall allergic rhinitis with montelukast alone or in combination with loratadine in a multicenter, double-blind, randomized, placebo-controlled study. J Allergy Clin Immunol 107:5158, 2001.
27. Philip G, Malmstrom K, Nayak A, et al. Improvement in rhinoconjunctivitis quality of life outcomes in the treatment of fall allergic rhinitis by montelukast alone or in combination with loratadine in a multicenter, double-blind, randomized, placebo-controlled study. J Allergy Clin Immunol 107:S158, 2001.
28. Wilson A, Orr L, Sims E, et al. Effects of monotherapy with intranasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 31:61-68, 2001.
29. Wilson A, Dempsey O, Sims E, et al. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin Exp Allergy 30:833-838, 2000.
30. Reicin A, White R, Weinstein S, et al. Montelukast, a leukotriene receptor antagonist, in combination with loratadine a histamine receptor antagonist, in the treatment of chronic asthma. Arch Int Med 160:2481-2488, 2000.